Skip to main content

Advertisement

SpringerLink
Log in

Ketogenic diet experience at Ondokuz Mayıs University

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background and objectives

The ketogenic diet (KD) is a special diet that is rich in fat, and poor in protein and carbohydrates. KD is the first-line treatment for some metabolic disorders, and is also used in resistant epilepsy, autism, cancer, Parkinson, Alzheimer’s diseases, and stroke. The KD team consists of a doctor (child neurologist), nurse, and dietician. After diet adjustment, family training, metabolic tests, consultations, material supply, the initial and follow-up stages are performed by this team.

Method

Retrospective data analyses of patients followed at ketogenic diet outpatient clinic were made.

Results

Fourteen patients (6F, 8M) continued their KD treatment, and nine (4F, 5M) of them stopped the treatment. KD treatment duration for those who continued KD was between 1 and 24 months (mean 7.1, median 4), and KD duration of those who left was between 0.5 and 12 months (mean 5, median 5). Three patients became seizure-free, seven patients had ≥ 50% reduction in their seizures, and four patients had no change in seizure. Anti-epileptic drugs could be reduced in five patients. Improvement in perception and social behaviour of the children was expressed by the families. Although one of the patients was seizure-free and the others had 75% decrease in seizures, they left KD due to frequent infection and family desire. The other seven patients who left KD had no changes in their seizures, but four of them continued KD in less than 2 months, and two of them only for 15 days. Weight loss, family problems, infection, and financial concerns were the reasons for them leaving.

Conclusion

Today, although the approach is changing, KD still comes to mind for the most resistant, troubled patients. Stopping the patients’ seizures, opening their perceptions, and reducing the medications are satisfactory results. We wanted to share our small group of patients and their results in the hope of expanding the ketogenic diet.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Suzuki Y, Takahashi H, Fukuda M et al (2009) Beta-hydroxybutyrate alters GABA-transaminase activity in cultured astrocytes. Brain Res 1268:17–23

    Article  CAS  Google Scholar 

  2. Stafstrom CE, Ockuly JC, Murphree L, Valley MT, Roopra A, Sutula TP (2009) Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models. Ann Neurol 65(4):435–447

    Article  CAS  Google Scholar 

  3. Hallbook T, Ji S, Maudsley S, Martin B (2012) The effects of the ketogenic diet on behavior and cognition. Epilepsy Res 100(3):304–309

    Article  Google Scholar 

  4. Lusardi TA, Akula KK, Coffman SQ, Ruskin DN, Masino SA, Boison D (2015) Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats. Neuropharmacology 99:500–509

    Article  CAS  Google Scholar 

  5. Kim DY, Abdelwahab MG, Lee SH et al (2015) Ketones prevent oxidative impairment of hippocampal synaptic integrity through KATP channels. PLoS One 10:e0119316

    Article  Google Scholar 

  6. Newell C, Bomhof MR, Reimer RA, Hittel DS, Rho JM, Shearer J (2016) Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder. Mol Autism 7:37

    Article  Google Scholar 

  7. Zhang Y, Xu J, Zhang K, Yang W, Li B (2018) The anticonvulsant effects of ketogenic diet on epileptic seizures and potential mechanisms. Curr Neuropharmacol 16(1):66–70. https://doi.org/10.2174/1570159X15666170517153509

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Boison D (2017) New insights into the mechanisms of the ketogenic diet. Curr Opin Neurol 30(2):187–192. https://doi.org/10.1097/WCO.0000000000000432

    Article  PubMed  PubMed Central  Google Scholar 

  9. Uyar GÖ, Şanlıer N (2018) The effect of ketogenic diet treatment in drug-resistant epilepsies of childhood. Turk Noroloji Dergisi 24(3):216

    Google Scholar 

  10. Kossoff EH, Zupec-Kania BA, Auvin S et al (2018) Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open 3(2):175–192

    Article  Google Scholar 

  11. Cai QY, Zhou ZJ et al (2017) Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J Pediatr 13(6):528–536

    Article  Google Scholar 

  12. Martin-McGill KJ, Jackson CF, Bresnahan R, Levy RG, Cooper PN (2018) Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev 11. https://doi.org/10.1002/14651858.CD001903.pub4

  13. Seo JH, Lee YM, Lee JS, Kang HC, Kim HD (2007) Efficacy and tolerability of the ketogenic diet according to lipid:nonlipid ratios--comparison of 3:1 with 4:1 diet. Epilepsia. 48(4):801–805

    Article  CAS  Google Scholar 

  14. Guzel O, Uysal U, Arslan N (2019) Efficacy and tolerability of olive oil-based ketogenic diet in children with drug-resistant epilepsy: a single center experience from Turkey. Eur J Paediatr Neurol 23(1):143–151

    Article  Google Scholar 

  15. Arslan N, Guzel O, Kose E et al (2016) Is ketogenic diet treatment hepatotoxic for children with intractable epilepsy? Seizure. 43:32–38

    Article  Google Scholar 

  16. Arslan N, Kose E, Guzel O (2017) The effect of ketogenic diet on serum selenium levels in patients with intractable epilepsy. Biol Trace Elem Res 178(1):1–6

    Article  CAS  Google Scholar 

  17. Kose E, Guzel O, Demir K, Arslan N (2017) Changes of thyroid hormonal status in patients receiving ketogenic diet due to intractable epilepsy. J Pediatr Endocrinol Metab 30(4):411–416

    Article  CAS  Google Scholar 

  18. Prezioso G, Carlone G, Zaccara G, Verrotti A (2018) Efficacy of ketogenic diet for infantile spasms: a systematic review. Acta Neurol Scand 137(1):4–11

    Article  CAS  Google Scholar 

  19. Hussain SA, Shin JH, Shih EJ et al (2016) Limited efficacy of the ketogenic diet in the treatment of highly refractory epileptic spasms. Seizure. 35:59–64

    Article  Google Scholar 

  20. Dressler A, Benninger F, Trimmel-Schwahofer P et al (2019) Efficacy and tolerability of the ketogenic diet versus high-dose adrenocorticotropic hormone for infantile spasms: a single-center parallel-cohort randomized controlled trial. Epilepsia. 60(3):441–451

    Article  CAS  Google Scholar 

  21. Wu Q, Wang H, Fan YY et al (2018) Ketogenic diet effects on 52 children with pharmacoresistant epileptic encephalopathy: a clinical prospective study. Brain Behav 8(5):e00973

    Article  Google Scholar 

  22. Lambrechts DA, de Kinderen RJ, Vles JS, de Louw AJ, Aldenkamp AP, Majoie HJ (2017) A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy. Acta Neurol Scand 135(2):231–239

    Article  CAS  Google Scholar 

  23. Garcia-Penas JJ (2018) Epilepsy, cognition and ketogenic diet. Rev Neurol 66(S01):S71–Ss5

    CAS  PubMed  Google Scholar 

  24. IJff DM, Postulart D, Lambrechts D et al (2016) Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: a randomized controlled trial. Epilepsy Behav 60:153–157

    Article  Google Scholar 

  25. Wirrell E, Eckert S, Wong-Kisiel L, Payne E, Nickels K (2018) Ketogenic diet therapy in infants: efficacy and tolerability. Pediatr Neurol 82:13–18

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank all the families for their participation and the dietician for the valuable contribution to this study.

Author information

Authors and Affiliations

  1. Department of Pediatric Neurology, Faculty of Medicine Maternity and Children Hospital, Giresun University, Giresun, Turkey

    Emine Tekin

  2. Pediatric Neurology, Antalya Training and Research Hospital, Antalya, Turkey

    Filiz Mıhçı Serdaroğlu

  3. Faculty of Medicine, Ketogenic Diet Policlinic, Ondokuz Mayıs University, Samsun, Turkey

    Şerife Şahin

  4. Faculty of Medicine, Department of Pediatric Neurology, Ondokuz Mayıs University, Samsun, Turkey

    Haydar Ali Taşdemir

Authors
  1. Emine Tekin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Filiz Mıhçı Serdaroğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Şerife Şahin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Haydar Ali Taşdemir
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emine Tekin.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Institutional ethical approval has been achieved.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tekin, E., Serdaroğlu, F.M., Şahin, Ş. et al. Ketogenic diet experience at Ondokuz Mayıs University. Neurol Sci 42, 2481–2485 (2021). https://doi.org/10.1007/s10072-020-04853-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04853-0

Keywords

Search

Navigation